Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis. - Wikidata - wikimedia - TriplyDB

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

http://www.wikidata.org/entity/Q43109248

about

High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study.Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemia Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin.Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators.Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.Statins decrease leptin expression in human white adipocytes.A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators.

P2860

Q33723646-8ECC6E76-C1C1-4606-83BA-076740D10399 Q33742998-314A5098-A9D2-47EB-8BE4-D28B9089D799 Q33748995-CA468530-0355-4FB2-8BFF-D83623079A0A Q34461505-E998B207-3C23-491F-8889-2C424C60171F Q34482501-817EE574-52DE-45FA-902A-9608183EAD6D Q35101262-068EAA9C-1380-467B-83F8-4B8141903D2B Q35830997-3B4187F4-244D-4B07-94AF-CCC8EA9B29A0 Q36180464-9F33C3E1-A9D2-4046-808B-C37E477CC25F Q36306780-6ED9B5FE-8296-42AD-A4BE-0D508E12B76F Q37011168-BCBA31EC-FC32-46DC-A18D-9F5763A48463 Q37831911-16051AFA-2CF3-4A51-881D-C20A0516BBC3 Q38976172-883B09B9-5E86-4678-A095-C07A018A1064 Q49413115-30DFFD94-3250-4B84-A294-470571AA24E4 Q51031273-4B0901DD-CB1D-47B8-B909-20095C01E9E8

P2860

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

http://www.wikidata.org/entity/Q43109248

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@en

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@nl

type

label

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@en

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@nl

prefLabel

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@en

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@nl

P1433

Q43109248-6F24B38D-5653-4FC3-82CD-4337213F5D40

P1476

Q43109248-BF8B5CA9-A76C-46EB-B034-889768B556B6

P2093

Q43109248-063CDD5A-C08B-4E83-B7A8-D9CAC2B5BDD6

Q43109248-4AF3441D-E3A5-408F-AF8E-17791A57A3FF

Q43109248-752BC148-C919-4B09-8CDF-ECC241CDD399

Q43109248-7E74C3F4-9DC8-4CAF-B2B7-AB2E8F56B23D

Q43109248-B15EDD8E-44A0-4CBB-9EF1-ED1F44E21346

Q43109248-CCCAFA6C-5741-434B-817F-44F1C60BA0D9

Q43109248-D1A7DB7B-3084-46B0-862B-FA8A83F165AD

Q43109248-E433A8A6-A6CF-4427-913F-35A7302FC491

P2860

Q43109248-03A442A0-158B-4144-875C-8B8C3ED1D7B3

Q43109248-03CB496C-1592-469C-9505-551D4AF17C10

Q43109248-09FA80FB-A816-471D-8747-54ABBADBD7D4

Q43109248-155D3574-DB61-4833-AAEE-DF17930C3666

Q43109248-3A432240-BA11-48B1-8DB5-E2B69554A2D3

Q43109248-411062FF-0992-48AD-9EFF-0E13B6EFC013

Q43109248-433281A0-FD07-4A9B-9EDA-CC4CA4A53D15

Q43109248-4D024175-6DA7-4788-8427-B51E03E56EBD

Q43109248-553C611A-82EC-4916-BDB5-65A5532113AC

Q43109248-6D0AA12B-E226-4969-B21C-F074EFA43870

P304

Q43109248-E9B48C97-2209-4E7C-BE08-9D208AC4718E

P31

Q43109248-C5743D2E-8066-43F3-8B15-5FBFDBBA0608

P356

Q43109248-81E3D93C-0F5F-4772-8883-5206DB834C3D

P407

Q43109248-57A63B9F-2B59-44B3-9E55-6D267BD814A5

P433

Q43109248-B00EEDE2-9844-40C7-8509-7C7172CB851D

P478

Q43109248-21027F35-2DA2-444F-8588-7D00E4314BF5

P50

Q43109248-3443B558-60B3-403E-8757-71993E33D2F8

P577

Q43109248-D454AEFF-83AF-4C3A-B3DA-4A0E81B06AF4

P5875

Q43109248-E4D8E1A9-EC71-4035-8A8C-9C8658A8D7FD

P698

Q43109248-B75E0D67-1622-4BFB-A0D5-2E465849018E

P921

Q43109248-E5884624-7D10-4B47-9B8D-5076503FB5D3

Q43109248-EF0FF1FD-3C50-4D20-866D-9EA7351071A3

P356

1479164109339966

P1433

Diabetes and Vascular Disease Research

P1476

Anti-inflammatory effects of s ...... with carotid atherosclerosis.

@en

P2093

Da-Wei Gong

http://www.w3.org/2001/XMLSchema#string

Dalong Zhu

http://www.w3.org/2001/XMLSchema#string

Guoyu Tong

http://www.w3.org/2001/XMLSchema#string

Jiajia Pan

http://www.w3.org/2001/XMLSchema#string

Kathy Ryan

http://www.w3.org/2001/XMLSchema#string

Rongze Yang

http://www.w3.org/2001/XMLSchema#string

Wei Xu

http://www.w3.org/2001/XMLSchema#string

Yun Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.

The effects of statin therapy on plasma markers of inflammation in patients without vascular disease.

Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective.

Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.

P304

262-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1479164109339966

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Shuldiner

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43023189

http://www.w3.org/2001/XMLSchema#string

P698

20368220

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis